GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...

Patients without diabetes using GLP-1RAs are less likely to develop glaucoma compared with those who use other weight loss therapies.

Delicious and extremely palatable food can increase the tendency of hedonic eating, where one consumes food for the sole ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...